Search

everythinglearnresearchcommunity

for

Search:↓

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Controlling transposable elements is crucial for successful tissue regeneration.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.